The role of inflammatory cytokines in the response of solid cancers to photodynamic therapy

Proceedings of SPIE - The International Society for Optical Engineering

Volumn 4248, Issue , 2001, Pages 107-113

  Korbelik, M ^a   Sun, J ^a   Cecic, I ^a   Dougherty, G J ^a  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; CELLS; IMMUNIZATION; ONCOLOGY; PHOTODYNAMIC THERAPY; PHOTOSENSITIZERS;

CYTOKINES; SOLID CANCERS;

TUMORS;

EID: 0034940908     PISSN: 0277786X     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.424442     Document Type: Conference Paper

References (57)

1. Photodynamic therapy
2. How does photodynamic therapy Work?
3. Induction of tumor immunity by photodynamic therapy
4. Antitumor immune reaction elicited by photodynamic therapy
5. Vascular effects of photodynamic therapy
6. Phospholipase activation triggers apoptosis in photosensitized mouse lymphoma cells
7. Hyaluronan
8. Depolymerisation products of hyaluronic acid after exposure to oxygen-derived free radicals
9. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages
10. Hyaluronan fragments activate an NF-kB/I-kBα autoregulatory loop in murine macrophages
11. Molecular mechanisms of leukocyte recruitment in the inflammatory process
12. Cellular targets and molecular responses associated with photodynamic therapy
13. Photodynamic therapy mediated induction of early response genes
14. Photodynamic therapy-mediated oxidative stress as a molecular switch for the temporal expression of genes ligated to the human heat shock promoter
15. Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo
16. Delayed phase of hematoporphyrin-induced phototoxicity: Modulation by complement, leukocytes, and antihistamines
17. Participation of mast cells and complement in the immediate phase of hematoporphyrin-induced phototoxicity
18. Complement activation during tumor photodynamic therapy
19. Biology of the complement system
20. Complement activation following oxidative stress
21. Reoxygenation of hypoxic human umbilical vein endothelial cells activates the classic complement pathway
22. Induction of immune cell infiltration into murine SCCVII tumour by Photofrin-based photodynamic therapy
23. Enhancement of tumor response to photodynamic therapy by adjuvant mycobacterium cell wall treatment
24. Contribution of myeloid and lymphoid host cells to the curative outcome of mouse sarcoma treatment by photodynamic therapy
25. Evidence for an important role of neutrophils in the eficacy of photodynamic therapy in vivo
26. Neutrophil-associated events in the inflammation of cancerous tissue following treatment with photodynamic therapy
27. The role of immune cells in PDT-induced death of cancer cells
28. Induction of systemic neutrophil response in mice by photodynamic therapy of solid tumors
29. Role of interleukin-1 and granulocyte colony-stimulating factor in photofrin-based photodynamic therapy of rat rhabdomyosarcoma tumors
30. A new biologic role for C3a and C3a des Arg: Regulation of TNF-α and IL-1 β Synthesis
31. The first subcomponent of complement, C1q triggers the production of IL-8, IL-6, and monocyte chemoattractant peptide- 1 by human umbilical vein endothelial cells
32. The membrane attack complex of complement induces interleukin-8, and monocyte chemoattractant protein-1 secretion from human umbilical vein endothelial cells
33. Acute phase response
34. Urinary cytokines following photodynamic therapy for bladder cancer. A preliminary report
35. Role of neutrophils in the destruction of PDT-targeted lesions
36. Present and future clinical relevance of interleukin 3
37. Interleukin-3 immunotherapy potentiates the curative effect of photodynamic therapy in treatment of cancerous lesions
38. Photodynamic therapy-mediated modulation of cellular cytokine expression: Il-10
39. The biology of interleukn-6
40. Monocyte induction of IL-10 and downregulation of IL- 12 by iC3b deposited in ultraviolet-exposed human skin
41. Properties and functions of interleukin-10
42. IL-10 contributes to the inhibition of contact hypersensitivity in mice treated with photodynamic therapy
43. Interleukin-12
44. Interleukin 15 induces endothelial hyaluronan expression in vitro and promotes activated T cell extravasation through a CD44-dependent pathway in vivo
45. Interleukin-18
46. Effect of photodynamic therapy on tumor necrosis factor production by murine macrophages
47. Phthalocyanine photodynamic therapy: Disparate effects of pharmacologic inhibitors on cutaneous photosensitivity and on tumor regression
48. Potentiation of photodynamic therapy in mice with recombinant human tumor necrosis factor-α
49. Photodynamic therapy-mediated oxidative stress as a molecular switch for the temporal expression of genes ligated to the human heat shock promoter
50. ®-based photodynamic therapy by localized treatment with G-CSF
51. G-CSF production in human bladder cancer and its ability to promote autocrine growth: A review
52. A case of cervical cancer with aggressive tumor growth: Possible autocrine stimulation by G-CSF and IL-6
53. Potentiation of photodynamic therapy-elicited antitumor response by localized treatment with granulocyte-macrophage colony-stimulating factor
54. Modulation of proinflammatory cytokine release from human polymorphonuclear leukocytes by gamma interferon
55. Antitumor activity of γ-interferon in ascitic and solid tumor models of human ovarian cancer
56. Endothelium-derived factors as paracrine mediators of prostate cancer progression
57. G-CSF in the biology and treatment of acute myeloid leukemia